Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathasha Bogoda

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Dietary Supplements|November 29, 2021
Palmitoylethanolamide: A Potential Alternative to CannabidiolPaul Clayton, Silma Subah, Ruchitha Venkatesh, et al.
International Journal of Molecular Sciences|June 2, 2021
Palmitoylethanolamide: A Natural Compound for Health ManagementPaul Clayton, Mariko Hill, Nathasha Bogoda, et al.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2020
Prenatal developmental toxicity study of an alkaloid-free Ageratum conyzoides extract powder in rats by oral administrationSilma Subah, Nathasha Bogoda, Róbert Glávits, et al.
Nature Microbiology|January 16, 2024
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsAnn-Kathrin Reuschl, Lucy G Thorne, Matthew V X Whelan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Dietary Supplements|November 29, 2021
Palmitoylethanolamide: A Potential Alternative to CannabidiolPaul Clayton, Silma Subah, Ruchitha Venkatesh, et al.
International Journal of Molecular Sciences|June 2, 2021
Palmitoylethanolamide: A Natural Compound for Health ManagementPaul Clayton, Mariko Hill, Nathasha Bogoda, et al.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2020
Prenatal developmental toxicity study of an alkaloid-free Ageratum conyzoides extract powder in rats by oral administrationSilma Subah, Nathasha Bogoda, Róbert Glávits, et al.
Nature Microbiology|January 16, 2024
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsAnn-Kathrin Reuschl, Lucy G Thorne, Matthew V X Whelan, et al.
Pageof 1